The effect of rituximab on patient reported outcomes in the preclinical phase of rheumatoid arthritis: 2 year data from the PRAIRI study.

Autor: Frazzei G; Department of Rheumatology and Clinical Immunology, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands.; Amsterdam Rheumatology and Immunology Center, Amsterdam, The Netherlands., Cramer SHM; Department of Rheumatology and Clinical Immunology, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands., Landewé RBM; Department of Rheumatology and Clinical Immunology, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands.; Amsterdam Rheumatology and Immunology Center, Amsterdam, The Netherlands.; Rheumatology, Zuyderland MC, Heerlen, The Netherlands., Maijer KI; Dermatology, Tergooi Hospital, Hilversum, The Netherlands., Gerlag DM; Department of Rheumatology and Clinical Immunology, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands.; UCB Pharma Ltd, Slough, UK., Tak PP; Department of Rheumatology and Clinical Immunology, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands.; Candel Therapeutics, Needham, Massachusetts, USA.; Research and Development, GSK, Stevenage, UK., de Vries N; Department of Rheumatology and Clinical Immunology, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands.; Amsterdam Rheumatology and Immunology Center, Amsterdam, The Netherlands., van Baarsen LGM; Department of Rheumatology and Clinical Immunology, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands.; Amsterdam Rheumatology and Immunology Center, Amsterdam, The Netherlands., van Vollenhoven RF; Department of Rheumatology and Clinical Immunology, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands.; Amsterdam Rheumatology and Immunology Center, Amsterdam, The Netherlands., Tas SW; Department of Rheumatology and Clinical Immunology, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands s.w.tas@amsterdamumc.nl.; Amsterdam Rheumatology and Immunology Center, Amsterdam, The Netherlands.

Publikováno v: RMD open [RMD Open] 2024 Oct 18; Vol. 10 (4). Date of Electronic Publication: 2024 Oct 18.

Safety and Efficacy of Bimekizumab in Patients with Psoriatic Arthritis: 2-Year Results from Two Phase 3 Studies.

Autor: Mease PJ; Department of Rheumatology, Providence-Swedish Medical Center and University of Washington, Seattle, WA, USA. pmease@philipmease.com., Merola JF; Harvard Medical School, Brigham and Women's Hospital, Boston, MA, USA., Tanaka Y; The First Department of Internal Medicine, University of Occupational and Environmental Health, Japan, Kitakyushu, Japan., Gossec L; Sorbonne Université, INSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique, Paris, France.; Rheumatology Department, AP-HP, Pitié-Salpêtrière Hospital, Paris, France., McInnes IB; College of Medical Veterinary and Life Sciences, University of Glasgow, Glasgow, UK., Ritchlin CT; Allergy, Immunology & Rheumatology Division, University of Rochester Medical School, Rochester, NY, USA., Landewé RBM; Amsterdam Rheumatology & Clinical Immunology Center, Amsterdam, and Zuyderland MC, Heerlen, The Netherlands., Asahina A; Department of Dermatology, The Jikei University School of Medicine, Tokyo, Japan., Ink B; UCB Pharma, Slough, UK., Heinrichs A; UCB Biosciences GmbH, Monheim, Germany., Bajracharya R; UCB Pharma, Slough, UK., Shende V; UCB Pharma, Slough, UK., Coarse J; UCB Pharma, Morrisville, NC, USA., Coates LC; Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Diseases, Oxford University Hospitals NHS Trust, University of Oxford and Oxford Biomedical Research Centre, Oxford, UK.

Publikováno v: Rheumatology and therapy [Rheumatol Ther] 2024 Oct; Vol. 11 (5), pp. 1363-1382. Date of Electronic Publication: 2024 Aug 31.

Goodbye to the term 'ankylosing spondylitis', hello 'axial spondyloarthritis': time to embrace the ASAS-defined nomenclature.

Autor: van der Heijde D; Rheumatology, Leiden University Medical Center, Leiden, The Netherlands mail@dvanderheijde.nl., Molto A; Rheumatology, Hospital Cochin, Paris, France.; Université Paris-Cité, INSERM U1153, Paris, France., Ramiro S; Rheumatology, Leiden University Medical Center, Leiden, The Netherlands.; Rheumatology, Zuyderland Medical Centre, Heerlen, The Netherlands., Braun J; Rheumazentrum Ruhrgebiet, Ruhr University Bochum, Herne, Germany., Dougados M; Hopital Cochin, Rheumatology, Université Paris Descartes Faculté de Médecine, Paris, France., van Gaalen FA; Rheumatology, Leiden University Medical Center, Leiden, The Netherlands., Gensler LS; Medicine/Rheumatology, University of California, San Francisco, California, USA., Inman RD; Schroeder Arthritis Institute, University Health Network, University of Toronto, Toronto, Ontario, Canada., Landewé RBM; Rheumatology, Zuyderland Medical Centre, Heerlen, The Netherlands.; Rheumatology, Amsterdam University Medical Center, Amsterdam, The Netherlands., Marzo-Ortega H; NIHR Leeds Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust and Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK., Navarro-Compán V; Rheumatology, University Hospital La Paz, IdiPaz, Madrid, Spain., Phoka A; ASIF, London, UK., Poddubnyy D; Gastroenterology, Infectious Diseases and Rheumatology (including Nutrition Medicine), Charité Universitätsmedizin Berlin, Berlin, Germany., Protopopov M; Gastroenterology, Infectious Diseases and Rheumatology (including Nutrition Medicine), Charité Universitätsmedizin Berlin, Berlin, Germany., Reveille J; Rheumatology, University of Texas McGovern Medical School, Houston, Texas, USA., Rudwaleit M; Internal Medicine and Rheumatology, Klinikum Bielefeld Rosenhöhe, Bielefeld, Germany., Sampaio-Barros P; Rheumatology, Faculdade de Medicina da Universidade de São Paulo e Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, Sao Paulo, Brazil., Sepriano A; Rheumatology, Leiden University Medical Center, Leiden, The Netherlands.; Nova Medical School, Universidade Nova de Lisboa, Lisboa, Portugal., Sieper J; Gastroenterology, Infectious Diseases and Rheumatology (including Nutrition Medicine), Charité Universitätsmedizin Berlin, Berlin, Germany., Van den Bosch FE; Rheumatology, Ghent University Hospital, Gent, Belgium.; Internal Medicine and Pediatrics, VIB-UGent Center for Inflammation Research, Ghent University, Gent, Belgium., van der Horst-Bruinsma I; Department of Rheumatology, Radboud University Medical Centre, Nijmegen, The Netherlands., Machado PM; Rheumatology and Neuromuscular Diseases, University College London, National Institute for Health Research (NIHR) University College London Hospitals (UCLH) Biomedical Research Centre, London, UK.; NHS Foundation Trust, London, UK.; Rheumatology, Norhwick Park Hospital, London North West University Healthcare NHS Trust, London, UK., Baraliakos X; Rheumazentrum Ruhrgebiet, Ruhr University Bochum, Herne, Germany.

Publikováno v: Annals of the rheumatic diseases [Ann Rheum Dis] 2024 Apr 11; Vol. 83 (5), pp. 547-549. Date of Electronic Publication: 2024 Apr 11.

Organ involvement and assessment in sarcoidosis.

Autor: Janssen MTHF; Department of Pulmonology., Landewé RBM; Department of Rheumatology, Zuyderland Medical Centre, Heerlen, Limburg.; Department of Clinical Immunology & Rheumatology, Amsterdam Rheumatology Centre, Amsterdam., Post MC; Department of Cardiology, St. Antonius Hospital Nieuwegein and Utrecht.; Department of Cardiology, University Medical Centre Utrecht, Utrecht., Erckens RJ; Department of Ophthalmology., Mostard RLM; Department of Pulmonology.; Department of Pulmonology, Maastricht University Medical Centre+, Maastricht, Limburg, The Netherlands.

Publikováno v: Current opinion in pulmonary medicine [Curr Opin Pulm Med] 2023 Sep 01; Vol. 29 (5), pp. 485-492. Date of Electronic Publication: 2023 Jul 17.

Controversies in rheumatology: telemedicine-friend or foe?

Autor: Dejaco C; Department of Rheumatology, Medical University Graz, Graz, Austria.; Department of Rheumatology, Hospital of Bruneck (ASAA-SABES), Teaching Hospital of the Paracelsus Medical University, Bruneck, Italy., Landewé RBM; Department of Rheumatology and Clinical Immunology, Amsterdam University Medical Center, Amsterdam, The Netherlands.; Deprtament of Rheumatology, Zuyderland Medical Center, Heerlen, The Netherlands.

Publikováno v: Rheumatology (Oxford, England) [Rheumatology (Oxford)] 2023 Aug 01; Vol. 62 (8), pp. 2661-2664.